Familial Risk of Pyoderma Gangrenosum
The available evidence does not provide specific data on familial inheritance or genetic risk of pyoderma gangrenosum (PG) when a family member has the condition. Unlike inflammatory bowel disease where familial clustering is well-documented, PG itself does not have established familial risk data in the current literature.
What the Evidence Shows
The provided guidelines and research focus on PG as:
- An autoinflammatory neutrophilic dermatosis 1
- A condition associated with immune-mediated diseases (inflammatory bowel disease, rheumatoid arthritis, hematologic disorders) 2, 1
- A disorder involving genetic predisposition combined with inflammation and immune dysfunction 3, 4
However, none of the evidence quantifies familial transmission risk or provides incidence rates among first-degree relatives of PG patients.
Context: IBD-Associated Familial Risk
The only familial risk data in the evidence relates to inflammatory bowel disease (IBD), not PG specifically. For ulcerative colitis, first-degree relatives have an incidence rate ratio of 4.08 (95% CI: 3.81-4.38) 5. Since approximately 0.6-2.1% of UC patients develop PG 2, one could theoretically have slightly elevated risk if a family member has both UC and PG, but this is indirect and not evidence-based for PG inheritance.
Clinical Reality
PG is considered a sporadic condition rather than a hereditary disease. The pathogenesis involves:
- Abnormal neutrophil function 2
- Immune-mediated dysfunction 4
- Genetic mutations that predispose to disease 3, 4
- Autoinflammatory mechanisms 1
The incidence in the general population is only 3-10 cases per million people 3, making it extremely rare. There is no established pattern of familial clustering or Mendelian inheritance for PG itself.
Practical Recommendation
Having a family member with PG does not meaningfully increase your risk of developing the condition based on current evidence. If your family member has an associated systemic disease (inflammatory bowel disease, rheumatoid arthritis, or hematologic disorder), your risk relates to inheriting that underlying condition, not PG directly.
Monitor for symptoms of the associated systemic diseases rather than PG specifically, as these underlying conditions carry documented familial risk and PG may develop as a secondary manifestation.